|
Tuesday, March 1 — 8:00 AM — CC 006 C/D
Click on the blue numbers in parentheses to display abstracts.
Click the  button next to any title to add to Itinerary Planner...
Section E - Gastrointestinal Pathology
Chaired by: Mamoun Younes and Gregory Lauwers
| Time | Title and Authors | Itinerary
Planner |
| 8:00 |
Eosinophilic Gastritis: Histopathologic Characterization and Quantification of the Normal Gastric Eosinophil Content.
(670)
SD Melton, RM Genta, T Lwin - VA North Texas Health Care System, Dallas; University of Texas Southwestern Medical Center, Dallas; Caris Life Sciences, Irving, TX
|  Add |
| 8:15 |
The Impact of Dropping the Requirements for Goblet Cells for the Diagnosis of Barrett's Esophagus (BE).
(723)
M Westerhoff, L Hovan, J Hart - University of Chicago, IL
| Add |
| 8:30 |
High Goblet Cell Density Protects Against Progression to Adenocarcinoma in Patients with Barrett's Esophagus.
(624)
K Golden, A Srivastava, CA Sanchez, PY Fong, X Li, DS Cowan, C Maley, PL Blount, BJ Reid, RD Odze - Brigham & Women's Hospital, Boston; Dartmouth Hitchcock Medical Center, Lebanon; Fred Hutchinson Cancer Center, Seattle; UCSF, San Francisco
| Add |
| 8:45 |
Identifying Low-Risk and High-Risk T1 Esophageal Adenocarcinoma Based on Pathologic Risk Factors.
(612)
J Davison, J Luketitch, M Gibson, R Landreneau, K Nason - UPMC, Pittsburgh, PA
| Add |
| 9:00 |
Measurement of Depth of Invasion, Submucosal and Lymphovascular Invasion (LVI) Predicts Lymph Node (LN) Involvement in T1 Esophageal Adenocarcinoma (EAC). Invasion of Duplicated Muscularis Mucosae (MM) Has Similar Risk of LN Involvement as Mucosal Invasion.
(619)
JS Estrella, W Hofstetter, AM Correa, J Ajani, S Swisher, A Rashid, D Maru - U.T. M.D. Anderson Cancer Center, Houston, TX
| Add |
| 9:15 |
Oncofetal Protein IMP3 as a Predictor of Prognosis in Gastric Adenocarcinoma.
(659)
M Lisovsky, Z Jiang, GY Lauwers - Dartmouth Hitchcock Medical Center, Lebanon, NH, Uzbekistan; UMassMemorial Medical Center, Worcester, MA; Massachusetts General Hospital, Boston
| Add |
| 9:30 |
RECESS, EXHIBITS, POSTER SESSION III
| |
| 11:00 |
Her2 Status in Gastric Adenocarcinoma: A Comparison of Immunohistochemistry (IHC), Fluorescent In-Situ Hybridization (FISH) and Dual Color Silver In-Situ Hybridization (SISH) Methods.
(728)
C Zhou, D Huntsman, B Carter, T Thomson, J Lorette, S Lee, L Bell, F Aubin, R Woods, H Lim, S Gill - British Columbia Cancer Agency, University of British Columbia, Vancouver, Canada
| Add |
| 11:15 |
HER2 Assessment in Gastric Cancer Surgical Specimens: Proposal of a Work-Flow for Practical Routine Use.
(595)
S Asioli, F Maletta, L Verdun di Cantogno, MA Satolli, M Schena, C Pecchioni, C Botta, G D'Angelo, D Recupero, G Ingravallo, E Maiorano, A Sapino - University of Turin, Italy; University of Bari, Italy
| Add |
| 11:30 |
"Pediatric-Type" Gastrointestinal Stromal Tumors in Adults: Distinctive Histology Predicts Genotype and Clinical Behavior.
(690)
TA Rege, AJ Wagner, CL Corless, JL Hornick - Brigham and Women's Hospital, Boston, MA; Dana Farber Cancer Institute, Boston, MA; Oregon Health and Science University, Portland
| Add |
| 11:45 |
Proposal for a More Applicable and Clinically Relevant Staging Evaluation of Ampullary Carcinomas.
(708)
T Tajiri, N Ohike, S Balci, GE Kim, A Krasinskas, O Basturk, N Dursun, M Goodman, D Kooby, S Maithel, J Sarmiento, C Staley, N Adsay - Showa University, Yokohama, Japan; Emory University, Atlanta, GA; UCSF, San Francisco, CA; UPMC, Pittsburgh, PA; MSKCC, NY
| Add |
|
|
